Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more
Peijia Medical Limited (PEJMF) - Total Assets
Latest total assets as of June 2025: $2.60 Billion USD
Based on the latest financial reports, Peijia Medical Limited (PEJMF) holds total assets worth $2.60 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Peijia Medical Limited - Total Assets Trend (2019–2024)
This chart illustrates how Peijia Medical Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Peijia Medical Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Peijia Medical Limited's total assets of $2.60 Billion consist of 36.7% current assets and 63.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.8% |
| Accounts Receivable | $101.04 Million | 3.8% |
| Inventory | $140.78 Million | 5.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $644.31 Million | 24.0% |
| Goodwill | $51.66 Million | 1.9% |
Asset Composition Trend (2019–2024)
This chart illustrates how Peijia Medical Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Peijia Medical Limited's current assets represent 36.7% of total assets in 2024, a decrease from 63.4% in 2019.
- Cash Position: Cash and equivalents constituted 24.8% of total assets in 2024, down from 57.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, unchanged from 24.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 24.0% of total assets.
Peijia Medical Limited Competitors by Total Assets
Key competitors of Peijia Medical Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Peijia Medical Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Peijia Medical Limited generates 0.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Peijia Medical Limited is currently not profitable relative to its asset base.
Peijia Medical Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.79 | 7.01 | 20.44 |
| Quick Ratio | 1.49 | 6.11 | 19.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $364.26 Million | $ 1.05 Billion | $ 2.31 Billion |
Peijia Medical Limited - Advanced Valuation Insights
This section examines the relationship between Peijia Medical Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.19 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 0.6% |
| Total Assets | $2.69 Billion |
| Market Capitalization | $578.72 Million USD |
Valuation Analysis
Below Book Valuation: The market values Peijia Medical Limited's assets below their book value (0.22 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Peijia Medical Limited's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Peijia Medical Limited (2019–2024)
The table below shows the annual total assets of Peijia Medical Limited from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.69 Billion | +0.63% |
| 2023-12-31 | $2.67 Billion | -19.43% |
| 2022-12-31 | $3.32 Billion | +4.83% |
| 2021-12-31 | $3.16 Billion | +9.80% |
| 2020-12-31 | $2.88 Billion | +227.61% |
| 2019-12-31 | $879.48 Million | -- |